The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection.
The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection.
复制标题
DOI:
10.1016/j.antiviral.2017.07.022
复制
发表时间:
2017-09
影响因子:
7.6
通讯作者:
Hohdatsu T
中科院分区:
文献类型:
--
作者:
Takano T;Endoh M;Fukatsu H;Sakurada H;Doki T;Hohdatsu T
Feline infectious peritonitis (FIP) is a feline coronavirus (FCoV)-induced fatal disease in wild and domestic cats. FCoV exists in two serotypes. Type I FCoV is the dominant serotype worldwide. Therefore, it is necessary to develop antiviral drugs against type I FCoV infection. We previously reported that type I FCoV is closely associated with cholesterol throughout the viral life cycle. In this study, we investigated whether U18666A, the cholesterol synthesis and transport inhibitor, shows antiviral effects against type I FCoV. U18666A induced cholesterol accumulation in cells and inhibited type I FCoV replication. Surprisingly, the antiviral activity of U18666A was suppressed by the histone deacetylase inhibitor (HDACi), Vorinostat. HDACi has been reported to revert U18666A-induced dysfunction of Niemann-Pick C1 (NPC1). In conclusion, these findings demonstrate that NPC1 plays an important role in type I FCoV infection. U18666A or other cholesterol transport inhibitor may be considered as the antiviral drug for the treatment of cats with FIP.
登录
查看更多内容
DOI:
10.1038/nrmicro.2016.81
发表时间:
2016-08
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
de Wit E;van Doremalen N;Falzarano D;Munster VJ
通讯作者:
Munster VJ
影响因子:
1.2
作者:
HOHDATSU, T;OKADA, S;KOYAMA, H
通讯作者:
KOYAMA, H
DOI:
10.1099/vir.0.070870-0
发表时间:
2015-03
期刊:
The Journal of general virology
影响因子:
--
作者:
Pratelli A;Colao V
通讯作者:
Colao V
影响因子:
3.3
作者:
Hohdatsu T;Sasamoto T;Okada S;Koyama H
通讯作者:
Koyama H
影响因子:
3.7
作者:
Gallagher TM;Buchmeier MJ
通讯作者:
Buchmeier MJ